SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-20-004396
Filing Date
2020-09-09
Accepted
2020-09-08 18:44:57
Documents
6
Period of Report
2020-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6039
2 EXHIBIT 5.1 exhibit5-1.htm EX-5.1 6631
3 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 8906
4 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 106907
5 GRAPHIC exhibit5-1x001.jpg GRAPHIC 6749
6 GRAPHIC exhibit99-1x001.jpg GRAPHIC 8761
  Complete submission text file 0001062993-20-004396.txt   151125
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 201165104
SIC: 2834 Pharmaceutical Preparations